CYC Secures Multi-Site Agreement with Northwestern Medicine
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Cyclopharm Limited has secured a multi-site agreement with Northwestern Medicine, a prominent health system in Chicago, enhancing its US commercial presence. The agreement includes an immediate installation of Technegas at Northwestern Memorial Hospital and potential for additional installations across the network. This strategic partnership is expected to generate recurring revenue and supports Cyclopharm's expansion strategy in key US healthcare markets. Management highlighted this agreement as a significant milestone in their US growth strategy, following a similar deal with the University of Pennsylvania Health System.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Earlier from Cyclopharm
- CYC Signs Enterprise Agreement with UPHS
- Preliminary Final Report
- Technegas US Footprint Expanding Across Four Regions
- Technegas Approved at the US National Institutes of Health
- Cyclopharm Capital Raising Investor Presentation
Later from Cyclopharm
- USA Technegas Expansion Update
- CYC First-Half 2026 Update
- Immediate 11-Site Technegas Rollout at University Hospitals
- ausbiz TV Presentation
- New US Lung Imaging Guidelines Name Technegas as Preferred A
Follow Cyclopharm into a list and get an email when it puts out news.
Follow Cyclopharm